RCKT logo

Rocket Pharmaceuticals (RCKT) Selling, General & Administrative Expenses

Annual SGA

$101.96 M
+$28.64 M+39.07%

December 1, 2024

Summary

Performance

1-Year Change

+39.07%

3-Year Change

+144.09%

5-Year Change

+458.87%

15-Year Change

+712.83%

RCKT SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.59%
RCKT annual SGA is higher than 72.59% of companies in Healthcare sector

High & Low

All-time High

$101.96 M
RCKT annual SGA is currently at an all-time high

3-Year Low

$41.77 M
RCKT annual SGA is currently +144.09% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
RCKT previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
RCKT next annual earnings announcement has not yet been scheduled

OtherRCKTexpensesmetrics:

Annual Total Expenses

$273.20 M
RCKT annual total expenses is $273.20 million

Annual Operating Expenses

$273.20 M
RCKT annual total operating expenses is $273.20 million

Annual Cost Of Goods Sold

-
RCKT annual cost of goods sold value is unknown

Annual Interest Expense

$1.89 M
RCKT annual interest expense is $1.89 million

Quarterly SGA

$25.34 M
-$1.77 M-6.54%

December 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+36.33%

5-Year Change

+36.33%

RCKT Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.53%
RCKT quarterly SGA is higher than 70.53% of companies in Healthcare sector

High & Low

All-time High

$27.37 M
RCKT quarterly SGA is currently -7.42% below its historical high of $27.37 million

3-Year Low

$11.32 M
RCKT quarterly SGA is currently +123.90% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
RCKT previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 6, 2025
RCKT next earnings announcement is scheduled for May 6, 2025

OtherRCKTexpensesmetrics:

Quarterly Total Expenses

$62.69 M
RCKT quarterly total expenses is $62.69 million

Quarterly Operating Expenses

$62.69 M
RCKT quarterly total operating expenses is $62.69 million

Quarterly Cost Of Goods Sold

-
RCKT quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$473.00 K
RCKT quarterly interest expense is $473.00 thousand

TTM SGA

-$4.49 B
-$258.75 M-6.12%

December 1, 2024

Summary

Performance

3-Month Change

-4502.07%

1-Year Change

-4502.07%

3-Year Change

-6437.13%

5-Year Change

-6437.13%

RCKT TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.26%
RCKT TTM SGA is higher than 9.26% of companies in Healthcare sector

High & Low

All-time High

-$118.51 M

3-Year Low

-$4.49 B
RCKT TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
RCKT previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 6, 2025
RCKT next earnings announcement is scheduled for May 6, 2025

OtherRCKTexpensesmetrics:

Annual Total Expenses

$273.20 M
RCKT annual total expenses is $273.20 million

Annual Operating Expenses

$273.20 M
RCKT annual total operating expenses is $273.20 million

TTM Cost Of Goods Sold

-
RCKT TTM cost of goods sold value is unknown

TTM Interest Expense

$1.89 M
RCKT TTM interest expense is $1.89 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$101.96 M
RCKT annual SGA is $101.96 million

Annual Operating Expenses

$273.20 M
RCKT annual total operating expenses is $273.20 million

Annual Cost Of Goods Sold

-
RCKT annual cost of goods sold value is unknown

RCKT Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.1%0.0%-4502.1%
3 y3 years+144.1%+36.3%-6437.1%
5 y5 years+458.9%+36.3%-6437.1%

RCKT Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+144.1%-7.4%+123.9%-164.0%at low
5 y5-yearat high+458.9%-7.4%+344.7%-628.9%at low
alltimeall timeat high+7601.0%-7.4%>+9999.0%-3687.4%at low

Rocket Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$101.96 M(+39.1%)
$25.34 M(-6.5%)
$101.96 M(+3.9%)
Sep 2024
-
$27.11 M(-0.9%)
$98.16 M(+9.5%)
Jun 2024
-
$27.37 M(+23.6%)
$89.64 M(+12.5%)
Mar 2024
-
$22.15 M(+2.8%)
$79.64 M(+8.6%)
Dec 2023
$73.32 M(+24.7%)
$21.54 M(+15.9%)
$73.32 M(+3.5%)
Sep 2023
-
$18.59 M(+7.0%)
$70.83 M(+5.2%)
Jun 2023
-
$17.37 M(+9.8%)
$67.35 M(+7.2%)
Mar 2023
-
$15.82 M(-16.9%)
$62.83 M(+6.9%)
Dec 2022
$58.77 M(+40.7%)
$19.05 M(+26.1%)
$58.77 M(+15.1%)
Sep 2022
-
$15.11 M(+17.5%)
$51.05 M(+11.1%)
Jun 2022
-
$12.85 M(+9.2%)
$45.97 M(+7.8%)
Mar 2022
-
$11.77 M(+4.0%)
$42.63 M(+2.1%)
Dec 2021
$41.77 M(+44.7%)
$11.32 M(+12.9%)
$41.77 M(+5.5%)
Sep 2021
-
$10.03 M(+5.3%)
$39.60 M(+12.2%)
Jun 2021
-
$9.52 M(-12.8%)
$35.31 M(+8.2%)
Mar 2021
-
$10.91 M(+19.3%)
$32.62 M(+13.0%)
Dec 2020
$28.86 M(+58.2%)
$9.14 M(+59.6%)
$28.87 M(+13.6%)
Sep 2020
-
$5.73 M(-16.1%)
$25.42 M(+5.8%)
Jun 2020
-
$6.83 M(-4.7%)
$24.02 M(+11.2%)
Mar 2020
-
$7.16 M(+25.7%)
$21.60 M(+18.4%)
Dec 2019
$18.24 M
$5.70 M(+31.4%)
$18.24 M(+18.4%)
Sep 2019
-
$4.34 M(-1.5%)
$15.41 M(+15.5%)
Jun 2019
-
$4.40 M(+15.6%)
$13.34 M(+2.3%)
DateAnnualQuarterlyTTM
Mar 2019
-
$3.81 M(+32.9%)
$13.04 M(-27.1%)
Dec 2018
$17.89 M(+42.6%)
$2.87 M(+26.3%)
$17.89 M(-26.8%)
Sep 2018
-
$2.27 M(-44.7%)
$24.46 M(+1.8%)
Jun 2018
-
$4.10 M(-52.7%)
$24.02 M(+16.5%)
Mar 2018
-
$8.66 M(-8.1%)
$20.62 M(+64.4%)
Dec 2017
$12.54 M(+26.8%)
$9.43 M(+414.8%)
$12.54 M(+113.9%)
Sep 2017
-
$1.83 M(+160.8%)
$5.86 M(-7.6%)
Jun 2017
-
$702.00 K(+20.0%)
$6.34 M(-20.3%)
Mar 2017
-
$585.00 K(-78.7%)
$7.96 M(-19.6%)
Dec 2016
$9.89 M(+26.2%)
$2.75 M(+18.8%)
$9.89 M(+4.6%)
Sep 2016
-
$2.31 M(-0.2%)
$9.46 M(+5.4%)
Jun 2016
-
$2.31 M(-8.2%)
$8.97 M(+7.0%)
Mar 2016
-
$2.52 M(+9.2%)
$8.38 M(+6.9%)
Dec 2015
$7.84 M(+271.3%)
$2.31 M(+26.5%)
$7.84 M(+24.3%)
Sep 2015
-
$1.82 M(+5.6%)
$6.31 M(+18.4%)
Jun 2015
-
$1.73 M(-12.7%)
$5.33 M(+35.5%)
Mar 2015
-
$1.98 M(+155.5%)
$3.93 M(+86.1%)
Dec 2014
$2.11 M(+59.5%)
$775.00 K(-8.1%)
$2.11 M(+48.8%)
Sep 2014
-
$843.00 K(+153.9%)
$1.42 M(+146.4%)
Jun 2014
-
$332.00 K(+104.9%)
$576.00 K(+136.1%)
Mar 2014
-
$162.00 K(+97.6%)
$244.00 K(+197.6%)
Dec 2013
$1.32 M(-42.6%)
$82.00 K
$82.00 K
Dec 2012
$2.31 M
-
-

FAQ

  • What is Rocket Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals annual SGA year-on-year change?
  • What is Rocket Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals quarterly SGA year-on-year change?
  • What is Rocket Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals TTM SGA year-on-year change?

What is Rocket Pharmaceuticals annual SGA?

The current annual SGA of RCKT is $101.96 M

What is the all time high annual SGA for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high annual SGA is $101.96 M

What is Rocket Pharmaceuticals annual SGA year-on-year change?

Over the past year, RCKT annual SGA has changed by +$28.64 M (+39.07%)

What is Rocket Pharmaceuticals quarterly SGA?

The current quarterly SGA of RCKT is $25.34 M

What is the all time high quarterly SGA for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high quarterly SGA is $27.37 M

What is Rocket Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, RCKT quarterly SGA has changed by $0.00 (0.00%)

What is Rocket Pharmaceuticals TTM SGA?

The current TTM SGA of RCKT is -$4.49 B

What is the all time high TTM SGA for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high TTM SGA is -$118.51 M

What is Rocket Pharmaceuticals TTM SGA year-on-year change?

Over the past year, RCKT TTM SGA has changed by -$4.59 B (-4502.07%)